6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 5G105

Ilko Ilac Sanayi ve Ticaret A.S

About Ilko Ilac Sanayi ve Ticaret A.S

ILKO Pharmaceuticals is a Fully Integrated Pharmaceutical Company with over 50 years of experience, focused on value-added and innovative products. Operating across Rx, biotechnology, high-potent non-sterile products and consumer health, ILKO combines strong R&D, drug development and advanced manufacturing capabilities, with particular expertise in high-potent and oncology products. With GMP, PIC/S and ISO 13485 certified infrastructure, ILKO exports to 40+ countries and is open to global partnerships through licensing, co-development, CMO/CDMO and technology transfer.

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 5G105
  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)
Contact info

Products from Ilko Ilac Sanayi ve Ticaret A.S (100)

  • Dasatinib

    Product Dasatinib

    Dasatinib is an oral tyrosine kinase inhibitor targeting BCR-ABL and other relevant kinases involved in malignant cell proliferation. It is available as 20 mg, 50 mg and 70 mg film-coated tablets in packs of 60, and as 100 mg and 140 mg film-coated tablets in packs of 30. The broad strength range supports ...
  • Erlotinib

    Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Sunitinib

    Product Sunitinib

    Sunitinib is an oral antineoplastic agent used in the treatment of selected solid tumors. It is a multi-targeted tyrosine kinase inhibitor that blocks several receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis and disease progression. The product is available in 12.5 mg, 25 mg and...
  • Ruxolitinib

    Product Ruxolitinib

    Ruxolitinib is an oral Janus kinase 1 and 2 inhibitor developed to modulate abnormal JAK-STAT signalling associated with selected haematological disorders. It is available as 5 mg, 10 mg, 15 mg and 20 mg tablets in multiple pack sizes, including 14, 56 and 168 tablets depending on the strength, supporting ...
  • Sorafenib

    Product Sorafenib

    Sorafenib is an oral multikinase inhibitor targeting signalling pathways involved in tumour-cell proliferation and tumour angiogenesis. It is available as 200 mg film-coated tablets in packs of 112, designed to support the established dosing schedule used in eligible oncology patients.  Expected ...
  • Palbociclib

    Product Palbociclib

    Palbociclib is an oral, selective inhibitor of cyclin-dependent kinases 4 and 6, designed to reduce tumour-cell proliferation by controlling cell-cycle progression. It is available as 75 mg, 100 mg and 125 mg tablets in packs of 7 or 21, supporting treatment cycles and individualized dose modification.Expe...
  • Betablok- Metoprolol Succinate

    Product Betablok- Metoprolol Succinate

    Metoprolol Succinate is a selective beta-1 adrenergic receptor blocker used in the management of several cardiovascular conditions. It reduces heart rate and cardiac workload by selectively blocking beta-1 receptors in the heart. The controlled-release formulation is designed to provide prolonged drug rele...
  • Valcodin- Valsartan/Amlodipine Besilate

    Product Valcodin- Valsartan/Amlodipine Besilate

    Valsartan / Amlodipine Besilate is a fixed-dose antihypertensive combination used in the management of hypertension. Valsartan is an angiotensin II receptor blocker (ARB), while amlodipine is a calcium channel blocker that promotes vasodilation. Their complementary mechanisms of action provide a combinatio...
  • Valcor Plus - Valsartan/Hydrochlorothiazide

    Product Valcor Plus - Valsartan/Hydrochlorothiazide

    Valsartan / Hydrochlorothiazide is a fixed-dose antihypertensive combination used in the management of hypertension. Valsartan is an angiotensin II receptor blocker (ARB) that reduces the effects of angiotensin II, while hydrochlorothiazide is a thiazide diuretic that promotes sodium and water excretion. T...
  • Livercol- Rosuvastatin Calcium

    Product Livercol- Rosuvastatin Calcium

    Rosuvastatin Calcium is a lipid-lowering agent belonging to the statin class. It selectively inhibits HMG-CoA reductase, a key enzyme involved in cholesterol synthesis, helping reduce low-density lipoprotein cholesterol (LDL-C) and total cholesterol while improving the overall lipid profile. The product is...
  • Flynta- Tadalafil

    Product Flynta- Tadalafil

    Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used in the treatment of erectile dysfunction and, at appropriate doses, certain lower urinary tract symptoms associated with benign prostatic hyperplasia. It works by enhancing nitric oxide–mediated vasodilation through inhibition of PDE5. The produ...
  • Romezon- Prednisone

    Product Romezon- Prednisone

    Prednisone is a systemic corticosteroid with anti-inflammatory and immunosuppressive properties, used in the management of a wide range of corticosteroid-responsive inflammatory, allergic and autoimmune conditions. It acts by modulating glucocorticoid-mediated pathways involved in immune and inflammatory r...

Ilko Ilac Sanayi ve Ticaret A.S Resources (2)